Quick Answer
PLIANT THERAPEUTICS, INC. reported Net Income Loss of -$149.34 million for the year ending 2025.
- PLIANT THERAPEUTICS, INC. showed an increase of +29.0% in Net Income Loss from 2024 to 2025.
- This data is from PLIANT THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), PLIANT THERAPEUTICS, INC.'s Net Income Loss has declined by 23,567.8%.
- Historical annual values: Fiscal year 2025: -$149.34 million | Fiscal year 2024: -$210.30 million | Fiscal year 2023: -$161.34 million | Fiscal year 2022: -$123.32 million | Fiscal year 2021: -$97.26 million | Fiscal year 2020: -$41.53 million | Fiscal year 2019: -$631.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: